PRKCB and breast carcinoma: For luminal A breast cancer, we observed that genes associated with favourable prognosis—including key regulators of glucose metabolism HK3, LDHAL6A, apoptosis regulator PRKCB, and alcohol dehydrogenase ADH6—are not directly targeted by current treatments.